The Pulse Of IP In International Pharma Today
Published on 24 February 2012 @ 1:09 pm
By Rachel Marusak Hermann for Intellectual Property Watch
High-level policymakers, industry leaders, law professors and other stakeholders came together in Geneva recently to discuss the how the role of intellectual property is evolving when it comes to developing, protecting, and providing medicines.








